EVIDENT Corporation Appoints New CEO and COO
Advertisement
Evident Corporation announced the appointment of William Wesley “Wes” Pringle as Chief Executive Officer (CEO) and Hiroyuki Yoshimoto as President and Chief Operating Officer (COO). Effective immediately, Wes takes over for Evident’s interim CEO Eric Anderson.
William Wesley “Wes” Pringle
Hiroyuki Yoshimoto
Wes has an impressive 30-year career driving growth and business transformation across a variety of industries, including consumer, industrial, healthcare and software-enabled businesses. Prior to joining Evident, Wes ran several companies for Danaher including Fluke Corporation (a global test and measurement leader), which he led for almost 10 years. As President of Fluke, Wes oversaw a period of significant growth and market expansion. More recently, he served as Head of Portfolio Operations at the private equity firm Onex Corporation, where he helped over a dozen portfolio companies accelerate performance.
Hiroyuki is an experienced leader with a proven track record of leading global companies headquartered in Japan and the USA. Prior to joining Evident, Hiroyuki had several senior leadership roles at global manufacturing companies such as Nissan Motor Corporation Group and Nidec Corporation. He led significant business growth by expanding market share and providing hands-on leadership for operational excellence. Most recently, he served as Senior Vice President and Japan Representative at American Express, where he led the business on a remarkable growth journey.
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
By submitting this form you agree that LUMITOS AG will send you the newsletter(s) selected above by email. Your data will not be passed on to third parties. Your data will be stored and processed in accordance with our data protection regulations. LUMITOS may contact you by email for the purpose of advertising or market and opinion surveys. You can revoke your consent at any time without giving reasons to LUMITOS AG, Ernst-Augustin-Str. 2, 12489 Berlin, Germany or by e-mail at revoke@lumitos.com with effect for the future. In addition, each email contains a link to unsubscribe from the corresponding newsletter.
Most read news
More news from our other portals
Last viewed contents
Danaher appoints Christopher Riley to Executive Vice President for Biotechnology
Biotage AB appointment of new CEO
Dr. Christine Munz becomes CEO at Eppendorf - Dr. Wilhelm Plüster completes term in office as planned
Beckman Coulter Life Sciences Names Joe Fox President
Nobel Prize in Medicine for immune system guardians - Two Americans and one Japanese scientist honored for revolutionary discoveries on the balance of the immune system in autoimmune diseases
GEA Supervisory Board takes early decision to extend contract of CEO Stefan Klebert - Company resolves to restructure the Executive Board and streamline the organizational structure as of January 1, 2026
Mosaic Therapeutics appoints Thomas Fuchs as CEO - Former CEO of Cimeio Therapeutics, and Global Haematology Franchise Head at Roche-Genentech, brings extensive track record of strategic and operational leadership
WIKA strengthens management team with Axel Schwerdtfeger - Process Solutions company division under new leadership
Otto Warburg Medal 2026 awarded to Maya Schuldiner
Research on rewiring neural circuit in fruit flies wins 2025 Eppendorf & Science Prize
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”